Acer Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Acer Therapeutics

27/03/2023 21:59

* Acer Therapeutics Inc  ACER.OQ  reported a quarterly
adjusted
loss of 54 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of 37 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Acer Therapeutics Inc's reported EPS for the quarter was a
loss
of 54 cents​.
    * The mean earnings estimate of analysts had risen by
about 0.9%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Acer Therapeutics Inc shares had fallen by 70.1% this
quarter.
    * The company reported a quarterly loss of $9.38 million.
    * Wall Street's median 12-month price target for Acer
Therapeutics
Inc is $8.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 27 at 08:59 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.37          -0.54          Missed
 Sep. 30 2022      -0.68          -0.31          Beat
 Jun. 30 2022      -0.57          -0.17          Beat
 Mar. 31 2022      -0.41          -0.64          Missed